Articoli Scientifici su Riviste Impattate SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications? di Redazione Dicembre 4, 2020 scritto da Redazione Dicembre 4, 2020 75 Articolo 0 commento Redazione messaggio precedente Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy prossimo post SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients Potrebbe piacerti anche “Women survive breast cancer but fall victim to heart failure: the shadows and lights of... Dicembre 5, 2020 “Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience” Dicembre 5, 2020 “Intracardiac metastasis originated from chondrosarcoma” Dicembre 5, 2020 “Complete atrioventricular block in a patient with intracardiac metastases from malignant melanoma” Dicembre 5, 2020 “Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors” Dicembre 5, 2020 “Early identification of left ventricular dysfunction induced by trastuzumab” Dicembre 5, 2020 “Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge” Dicembre 5, 2020 “Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer” Dicembre 5, 2020 “Administration of angiotensin-coverting enzyme inhibitors and B-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer:... Dicembre 5, 2020 “Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a... Dicembre 5, 2020
